Skip to main content
OpenTrials

Clinical trial condition

Movement Disorders

Explore clinical trials studying Movement Disorders. Study availability and eligibility vary by location and protocol.

4,246 public trials 785 recruiting studies
Refine in advanced search Browse all conditions

Movement Disorders trial results

Completed

A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

NCT03670953

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Xenoscience, Inc. (102) Phoenix, Arizona, United States
  • St. Joseph's Hospital & Medical Center/ Barrow Neurological Institute (156) Phoenix, Arizona, United States
  • Clinical Trials, Inc. (113) Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences (117) Little Rock, Arkansas, United States
View all 108 locations
View Trial Details
Completed

NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa

NCT05083260

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Rocky Mountain Movement Disorders Center Englewood, Colorado, United States
  • Parkinson's Disease & Movement Disorders Center Of Boca Raton Boca Raton, Florida, United States
  • Velocity Hallandale, Florida, United States
  • Charter Research Lady Lake, Florida, United States
View all 16 locations
View Trial Details
Completed

Study to Assess Participant/Caregiver/Investigator Satisfaction of Video-Assisted Telenursing in Adult Participants With Parkinson's Disease Treated With Levodopa-Carbidopa Intestinal Gel

NCT04500106

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Royal Brisbane and Women's Hospital /ID# 223138 Herston, Queensland, Australia
  • Kingston Centre /ID# 222563 Cheltenham, Victoria, Australia
  • The Royal Melbourne Hospital /ID# 223005 Parkville, Victoria, Australia
  • Soroka University Medical Center /ID# 222754 Beersheba, Southern District, Israel
View all 13 locations
View Trial Details
Completed

An Open Label Study of ANX005 in Subjects With, or at Risk for, Manifest Huntington's Disease

NCT04514367

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • Annexon Investigational Site 02 Birmingham, Alabama, United States
  • Annexon Investigational Site 03 Englewood, Colorado, United States
  • Annexon Investigational Site 04 Washington D.C., District of Columbia, United States
  • Annexon Investigational Site 07 Durham, North Carolina, United States
View Trial Details

Related conditions